Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine

Not Applicable

Completed

Conditions: Fanconi Anemia

Interventions: Drug: Cyclophosphamide
Drug: Fludarabine
Radiation: Total body irradiation (TBI)

First Posted Date: 2008-01-16

Last Posted Date: 2016-08-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 21

Registration Number: NCT00595127

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma

Not Applicable

Completed

Conditions: Primary Brain Tumor
Brain Cancer
Recurrent Malignant Gliomas

Interventions: Other: bevacizumab and radiation (IMRT)

First Posted Date: 2008-01-16

Last Posted Date: 2017-05-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT00595322

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma

Not Applicable

Completed

Conditions: SQUAMOUS CELL CARCINOMA

Interventions: Drug: celecoxib

First Posted Date: 2008-01-16

Last Posted Date: 2015-12-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 12

Registration Number: NCT00596219

Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Not Applicable

Completed

Conditions: Lymphoma

Interventions: Drug: Cytarabine, Leucovorin, Methotrexate, Procarbazine, Rituximab, Vincristine

First Posted Date: 2008-01-16

Last Posted Date: 2017-04-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 52

Registration Number: NCT00594815

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

Phase 2

Completed

Conditions: CNS Lymphoma
CNS Brain Cancer
Non-Hodgkin's Lymphoma

Interventions: Other: Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide

First Posted Date: 2008-01-16

Last Posted Date: 2024-04-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 33

Registration Number: NCT00596154

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States

Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors

Phase 1

Completed

Conditions: Brain Tumor
Cns Cancer
Brain Cancer
Cognitive Dysfunction

Interventions: Other: donepezil and questionaires

First Posted Date: 2008-01-16

Last Posted Date: 2016-01-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT00594633

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Model for Genetic Susceptibility: Melanoma

Active, not recruiting

Conditions: Melanoma
Skin Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2008-01-11

Last Posted Date: 2024-08-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 4082

Registration Number: NCT00591500

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Cancer Control Following Polypectomy

Completed

Conditions: Colon Cancer

First Posted Date: 2008-01-11

Last Posted Date: 2023-09-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 110

Registration Number: NCT00591279

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Magnetic Resonance Imaging and Spectroscopy of the Prostate

Completed

Conditions: Prostate Cancer

Interventions: Other: MRI and MRSI

First Posted Date: 2008-01-11

Last Posted Date: 2023-10-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1005

Registration Number: NCT00590993

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Evaluation of the Compress Distal Femoral Replacement System

Phase 1

Completed

Conditions: Lower Thighbone and Knee Joint Replacement

Interventions: Device: ComPreSs Distal Femoral Replacement System.

First Posted Date: 2008-01-11

Last Posted Date: 2023-06-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 26

Registration Number: NCT00591812

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy